Aphria Inc. is pleased to announce that effective at the open of the market today, Aphria's common shares will be listed and will commence trading on the TSX Venture Exchange (the "TSX-V") under the ticker symbol "APH".
On December 2, 2014, Aphria, formerly named Black Sparrow Capital Corp. announced shareholder approval of its previously announced business combination (the "Transaction"). The Transaction has now received all final approvals, including the final approval of the TSXV. The total number of issued and outstanding common shares of Aphria at the resumption of trading will be 52,479,587, expressed on a non-diluted basis.
Cole Cacciavillani, Chief Operating Officer of Aphria, was issued and has acquired control of, directly or indirectly, an aggregate of 9,944,444 common shares of Aphria in connection with the completion of the Transaction. As a result of the combination, Mr. Cacciavillani collectively owns or controls, directly or indirectly, an aggregate of 9,944,444 common shares, and controls the right to acquire an additional 500,000 common shares upon the exercise of 500,000 incentive stock options. Such securities represent 18.9% of Aphria's issued and outstanding common shares (or approximately 19.7 % on a partially diluted basis assuming conversion of Mr. Cacciavillani's options).
John Cervini, Chief Agronomist Officer of Aphria, was issued and has acquired control of, directly or indirectly, an aggregate of 11,500,011 common shares of Aphria in connection with the completion of the Transaction. As a result of the combination, Mr. Cervini collectively owns or controls, directly or indirectly, an aggregate of 11,500,011 common shares, and controls the right to acquire an additional 500,000 common shares upon the exercise of 500,000 incentive stock options. Such securities represent 21.9% of Aphria's issued and outstanding common shares (or approximately 22.7% on a partially diluted basis assuming conversion of Mr. Cervini's options).
The securities are held for investment purposes, and Mr. Cacciavillani and Mr. Cervini may acquire additional securities, or dispose of their holdings of securities as investment conditions warrant, subject to applicable escrow requirements of the TSX-V. Copies of the reports filed in connection with these share ownerships are available under Aphria's corporate profile at Welcome to the SEDAR Web Site / Bienvenue au Site Web SEDAR
About Aphria
Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria. The head office of Aphria is located at 5300 Commerce Court West, 199 Bay Street, Toronto, ON, M5L 1B9.
News Moderator: Shandar @ 420 MAGAZINE ®
Source: Stock Market, Finance & Business News | Yahoo Finance Canada
Contact: Stock Market, Finance & Business News | Yahoo Finance Canada
Website: Aphria Inc. Begins Trading on the TSXV
On December 2, 2014, Aphria, formerly named Black Sparrow Capital Corp. announced shareholder approval of its previously announced business combination (the "Transaction"). The Transaction has now received all final approvals, including the final approval of the TSXV. The total number of issued and outstanding common shares of Aphria at the resumption of trading will be 52,479,587, expressed on a non-diluted basis.
Cole Cacciavillani, Chief Operating Officer of Aphria, was issued and has acquired control of, directly or indirectly, an aggregate of 9,944,444 common shares of Aphria in connection with the completion of the Transaction. As a result of the combination, Mr. Cacciavillani collectively owns or controls, directly or indirectly, an aggregate of 9,944,444 common shares, and controls the right to acquire an additional 500,000 common shares upon the exercise of 500,000 incentive stock options. Such securities represent 18.9% of Aphria's issued and outstanding common shares (or approximately 19.7 % on a partially diluted basis assuming conversion of Mr. Cacciavillani's options).
John Cervini, Chief Agronomist Officer of Aphria, was issued and has acquired control of, directly or indirectly, an aggregate of 11,500,011 common shares of Aphria in connection with the completion of the Transaction. As a result of the combination, Mr. Cervini collectively owns or controls, directly or indirectly, an aggregate of 11,500,011 common shares, and controls the right to acquire an additional 500,000 common shares upon the exercise of 500,000 incentive stock options. Such securities represent 21.9% of Aphria's issued and outstanding common shares (or approximately 22.7% on a partially diluted basis assuming conversion of Mr. Cervini's options).
The securities are held for investment purposes, and Mr. Cacciavillani and Mr. Cervini may acquire additional securities, or dispose of their holdings of securities as investment conditions warrant, subject to applicable escrow requirements of the TSX-V. Copies of the reports filed in connection with these share ownerships are available under Aphria's corporate profile at Welcome to the SEDAR Web Site / Bienvenue au Site Web SEDAR
About Aphria
Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the "MMPR"). Under the MMPR, Health Canada is responsible for the oversight of commercial medical marijuana growers such as Aphria. The head office of Aphria is located at 5300 Commerce Court West, 199 Bay Street, Toronto, ON, M5L 1B9.
News Moderator: Shandar @ 420 MAGAZINE ®
Source: Stock Market, Finance & Business News | Yahoo Finance Canada
Contact: Stock Market, Finance & Business News | Yahoo Finance Canada
Website: Aphria Inc. Begins Trading on the TSXV
